Physician profile
Brooke Ritter
NPI 1063672335
$1,369.37
in general payments reported to CMS, 2019-2025
21 companies · $49.38 in 2025
The $49.38 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $164 · 2021: $234 · 2022: $214 · 2023: $178 · 2024: $216 · 2025: $49.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.77 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $277.70 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $260.95 | 2023-2024 | Veozah |
| Allergan, INC. | $144.99 | 2019-2020 | |
| Pfizer INC. | $144.51 | 2019-2023 | |
| Gynesonics, INC. | $114.33 | 2021 | |
| Boston Scientific Corporation | $57.05 | 2023-2025 | General - Atherectomy |
| Therapeuticsmd, INC. | $48.66 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $39.90 | 2019 | |
| Coopersurgical, INC. | $39.47 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.21 | 2019 | |
| Agile Therapeutics, INC. | $27.30 | 2021-2022 | |
| Exeltis, USA INC. | $26.35 | 2019-2020 | |
| Covidien LP | $25.96 | 2019 | |
| Medtronic Vascular, INC. | $19.44 | 2020 | |
| Shield Therapeutics INC | $17.52 | 2023 | Accrufer |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $16.77 | 2020 | |
| Scynexis, INC. | $16.00 | 2022 | |
| Ascend Therapeutics US, LLC | $14.95 | 2022 | |
| Hologic Sales and Service, LLC | $14.73 | 2025 | Fluent Fluid Management System, Acessa Provu System, Novasure |
| Daiichi Sankyo INC. | $13.89 | 2019 | |
| Siemens Medical Solutions USA, INC. | $13.69 | 2023 | Mammomat Revelation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Ritter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.